First Horizon Corporation Common Stock vs IQVIA Holdings Inc. Common Stock — how do they compare? First Horizon Corporation Common Stock trades at $22.63 (market cap $10.74B), while IQVIA Holdings Inc. Common Stock trades at $262.52 (market cap $43.13B). The key difference: IQVIA Holdings Inc. Common Stock is far larger — about 4× First Horizon Corporation Common Stock's market cap, and First Horizon Corporation Common Stock pays a 3% dividend while IQVIA Holdings Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold First Horizon Corporation Common Stock for 0 Days and IQVIA Holdings Inc. Common Stock for 6 Days on average.
| FHN | IQV | |
|---|---|---|
Market Cap | $10.74B | $43.13B |
Volume | 11,773,440 | 847,300 |
Sector | Financials | Health |
52-Week High | $26.23 | $275.02 |
52-Week Low | $19.94 | $156.66 |
Typical Hold Time | 0 Days | 6 Days |
Enterprise Value | $14.03B | $57.29B |
Dividend Yield | 3% | — |
Signals from Pluang's Aura AI — not financial advice
First Horizon (FHN) trades at $22.77, down 1.26% on the day, with a neutral technical outlook. The stock shows strong fundamentals, including a P/E of 10.95 and net income margin of 30.87% for 2026, supported by three consecutive quarterly earnings beats. Recent news highlights executive recognitions and upcoming Q3 2026 earnings on October 15, 2026.
The outlook is positive given robust profitability, analyst consensus price target of $27.44 (20.5% upside), and no sell ratings. Risks include high debt-to-asset ratio of 1.81 and macroeconomic sensitivity. Earnings growth remains the key catalyst for further upside, with investor focus on Q3 results.
IQVIA Holdings (IQV) trades at $260.71, down 0.57% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $284.64. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $3.15 surpassing the $3.03 estimate. Revenue growth is steady, projected at $17.0B for 2026, while profitability metrics like a 23.01% ROE and 8.1% net income margin reflect operational strength. The company continues to innovate, launching new predictive analytics tools for life sciences clients.
The outlook for IQV remains positive, supported by strong earnings performance and analyst optimism, though investors should note valuation multiples above sector averages and debt levels. Key risks include competitive pressures in clinical research services and macroeconomic sensitivity affecting client spending.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
First Horizon Corporation is the holding company for First Horizon Bank, a regional financial services provider operating roughly 460 branches across 11 states in southeastern US. It offers commercial, consumer, private banking, wealth management, and capital markets services.
Read more on FHN →IQVIA provides clinical research, healthcare data, technology, and consulting services to life sciences companies. Its work supports drug development and commercialization.
Read more on IQV →